Clinical Trial Update: Open Label Treatment With tDCS for Parkinson's and Related Disorders for Improvement of Speech, Gait and Mood [Phase 1]

View source ↗

Summary

An open-label Phase 1 trial evaluating transcranial direct current stimulation (tDCS) for improving speech, gait, and mood in Parkinson's disease and related di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Transcranial Direct Current Stimulation (tDCS) (transcranial direct current stimulation)

Snippet

Sponsor: Georgetown University | Conditions: Parkinson's Disease | Phase 1 | Status: COMPLETED